COMMUNIQUÉS West-GlobeNewswire

Zosano Pharma to Present Phase 3 Safety Study Update for ADAM™ Technology in the Delivery of Zolmitriptan at the 5th Annual Transdermal & Intradermal Drug Delivery Systems Conference
06/09/2018
FREMONT, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, developing and commercializing therapies that deliver [...]
Ortho RTi Signs Agreement with a Leading CMO for the Manufacture of cGMP Finished Dosage Form Ortho-R in Preparation for Planned First-in-Human Study
06/09/2018
KIRKLAND, Quebec, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. ( CSE: ORTH ) (“ Ortho RTi ” or the “ Corporation ”), an emerging Orthopaedic and Sports Medicine Technology company, today [...]
ContraFect Completes Enrollment in Phase 2 Clinical Trial Evaluating CF-301 (exebacase) in Patients with Staphylococcus Aureus Bacteremia
06/09/2018
Company remains on track to announce top-line results in Q4 2018 YONKERS, N.Y., Sept. 06, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery [...]
Golden Leaf Holdings Adds Chief Marketing and Sales Officer to Business Development Team
06/09/2018
Jeff Yapp joins as Chief Marketing and Sales Officer to bolster business development team and strengthen Company’s brand recognition and customer relations TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Golden Leaf [...]
Vaxil Appoints Veteran Pharma Executive David Goren as CEO
06/09/2018
Provides Corporate Update Including Tuberculosis Vaccine Pre-Clinical Studies and ongoing Manufacturing Testing NESS-ZIONA, ISRAEL, Sept. 06, 2018 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (TSX VENTURE: VXL), an Israeli [...]
Dr. William J. Foster Joins Altasciences as Principal Investigator
06/09/2018
LAVAL, Quebec, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Altasciences is pleased to welcome Dr. William J. Foster, MD, PhD, FRCSC, to the Altasciences family as Principal Investigator and Consultant on clinical trials. Dr. [...]
Le docteur William J. Foster se joint à l’équipe d’Altasciences à titre de chercheur principal
06/09/2018
LAVAL, Québec, 06 sept. 2018 (GLOBE NEWSWIRE) -- Altasciences est fière de souhaiter la bienvenue au docteur William J. Foster, M.D., Ph. D., FRCSC, qui se joint à l’équipe à titre de chercheur principal et de [...]
CLS Holdings USA Announces Increased Sales Growth at Oasis Cannabis
06/09/2018
Entering Second Full Year of Legalized Adult Use in Las Vegas, Nevada LAS VEGAS, Sept. 06, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life [...]
Matinas BioPharma Announces Appointment of Industry Leader Patrick G. LePore to Board of Directors
06/09/2018
BEDMINSTER, N.J., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling targeted intracellular delivery of life-changing [...]
HempAmericana Commences Initial CBD Oil Production in $2.1B CBD Market
06/09/2018
NEW YORK, Sept. 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is thrilled to announce the commencement of initial CBD Oil production at its principal [...]
Forty Seven Inc. to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
06/09/2018
MENLO PARK, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
Evelo Biosciences to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
06/09/2018
CAMBRIDGE, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing monoclonal microbials designed to act on the gut-body network for [...]
Chiesi Partnership with Durham Bulls Closes Season with $15,000 to Area Nonprofits
06/09/2018
The company’s presenting strikeout partnership is a homerun for three local charities CARY, N.C., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Leading into the first pitch at the Durham Bulls August 31 home game against the [...]
Melinta Therapeutics to Host Meetings at the Morgan Stanley 16th Annual Global Healthcare Conference
06/09/2018
NEW HAVEN, Conn., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
AMAG Pharmaceuticals Pays Off $475 Million of Senior Secured Notes
06/09/2018
Early Retirement of more than $800 million in debt since mid-2017 significantly strengthens balance sheet WALTHAM, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that [...]
Bespoke Extracts and Hip Hop Mega-Celebrity Soulja Boy to Collaborate on Development of Co-Branded CBD Product Line
06/09/2018
SUNNY ISLES, Fla., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD products, today announced that Grammy-nominated, American Hip Hop [...]
GBT Brings Together Sickle Cell Disease Influencers at 7th Annual Sickle Cell Disease (SCD) Therapeutics Conference
06/09/2018
Healthcare Providers, Patient Advocates and Policy Makers Will Discuss Issues Impacting SCD Community During National SCD Awareness Month Livestream of Conference Will Be Available through Collaboration with Sickle Cell [...]
Tower One September Update
06/09/2018
VANCOUVER, British Columbia, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) announces a comprehensive update on recent company [...]
Soleno Therapeutics Announces Expansion of Ongoing Phase III Trial of DCCR in Prader-Willi Syndrome to Include Younger Patients
06/09/2018
Amendment Lowers Minimum Age Inclusion Criteria to Four Years, from Eight Years, to Better Reflect Demographics of PWS Population Top-line Data from Phase III Trial Expected in First Half of 2019 REDWOOD CITY, Calif., [...]

Pages